NIH undertakes public‐private opioid initiative | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Premium

NIH undertakes public‐private opioid initiative

Publication year - 2017

Publication title -

the brown university child and adolescent psychopharmacology update

Language(s) - English

Resource type - Journals

eISSN - 1556-7567

pISSN - 1527-8395

DOI - 10.1002/cpu.30227

Subject(s) - general partnership , chronic pain , opioid , opioid abuse , opioid use disorder , medicine , opioid overdose , public health , substance abuse , opioid epidemic , political science , psychiatry , public administration , nursing , (+) naloxone , receptor , law

The National Institute on Drug Abuse (NIDA), under the leadership of Francis S. Collins, M.D., Ph.D., director of the National Institute of Health (NIH), is moving forward to establish a public‐private partnership addressing three major areas: (1) new and innovative medications to treat opioid use disorders and for overdose prevention and reversal; (2) safe, effective and nonaddictive strategies to manage chronic pain; and (3) neurobiology of chronic pain.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here

Accelerating Research